SCHEMBL346764

SCHEMBL346764

O=C1OC(=O)C2=C1C1CCC2CC1

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.35
TDP1 Q9NUW8 2/20 0.31
KDM4E B2RXH2 1/20 0.31
GMNN O75496 1/20 0.31
PPM1B O75688 1/20 0.31
LMNA P02545 1/20 0.31
PPP1CC P36873 1/20 0.31
TFPI2 P48307 1/20 0.31
RAB9A P51151 1/20 0.31
PPP5C P53041 1/20 0.31
PPP1CA P62136 1/20 0.31
PMP22 Q01453 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
TP53 P04637 1/20 0.31
CYP2D6 P10635 1/20 0.31
NFKB1 P19838 1/20 0.31
THPO P40225 1/20 0.31
ALOX15 P16050 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2647824 0.92 TSHR (0.31) TSHR
SCHEMBL10759055 0.88 TSHR (0.32) TSHR
SCHEMBL346876 0.88 TSHR (0.32) TSHR
SCHEMBL304318 0.88 CEL (0.33) TSHR
SCHEMBL561422 0.88 TSHR (0.32) TSHR
SCHEMBL6238652 0.86 KMT2A (0.36)
SCHEMBL15751193 0.82 ESR2 (0.36) TSHRLMNASMN1; SMN2TP53
SCHEMBL15751190 0.82 ESR2 (0.36) TSHRLMNASMN1; SMN2TP53
SCHEMBL18022413 0.73
SCHEMBL10679447 0.71 KMT2A (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 224 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116589666-A Polyester polyol and preparation method and application thereof 杭州之江有机硅化工有限公司 2023-08-15 CN claimed
US-12534606-B2 Functionalized propylene based elastomer composition and method of making EXXONMOBIL CHEMICAL PATENTS INC. (US) 2026-01-27 US disclosed
US-20250179054-A1 THRB RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD AND USE THEREOF TERNS PHARMACEUTICALS, INC. 2025-06-05 US disclosed
EP-3277752-B1 PROPYLENE-BASED POLYMER COMPOSITIONS FOR GRIP APPLICATIONS EXXONMOBIL CHEMICAL PATENTS INC (US) 2024-09-18 EP disclosed
EP-3752538-B1 METALLOCENE CATALYST FEED SYSTEM FOR SOLUTION POLYMERIZATION PROCESS EXXONMOBIL CHEMICAL PATENTS INC (US) 2024-07-03 EP disclosed
EP-4077536-B1 FUNCTIONALIZED PROPYLENE BASED ELASTOMER COMPOSITION AND METHOD OF MAKING EXXONMOBIL CHEMICAL PATENTS INC (US) 2024-01-31 EP disclosed
US-20240011198-A1 Nonwoven Fabrics with Improved Haptics and Mechanical Properties EXXONMOBIL CHEMICAL PATENTS INC (US) 2024-01-11 US disclosed
US-20230357454-A1 Methods for Delivery of Non-Aromatic Solutions to Polymerization Reactors EXXONMOBIL CHEMICAL PATENTS INC (US) 2023-11-09 US disclosed
US-11780981-B2 Foam beads and method of making the same EXXONMOBIL CHEMICAL PATENTS INC. (US) 2023-10-10 US disclosed
EP-4248004-A1 NONWOVEN FABRICS WITH IMPROVED HAPTICS AND MECHANICAL PROPERTIES ExxonMobil Chemical Patents Inc. (US) 2023-09-27 EP disclosed
US-6465462-B1 COGNITION ENHANCEMENT FOR DEMENTING ILLNESSES SUCH AS ALZHEIMER'S DISEASE MERCK SHARP & DOHME LTD. 2002-10-15 US disclosed
US-6255305-B1 PSYCHOLOGICAL DISORDERS MERCK SHARP & DOHME LIMITED (GB) 2001-07-03 US disclosed
EP-0915877-A1 SUBSTITUTED TRIAZOLO PYRIDAZINE DERIVATIVES AS INVERSE AGONISTS OF THE GABA A?$g(a)5 RECEPTOR SUBTYPE MERCK SHARP & DOHME LTD. (GB) 1999-05-19 EP disclosed
EP-0915875-A2 SUBSTITUTED TRIAZOLO-PYRIDAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS MERCK SHARP & DOHME LTD. (GB) 1999-05-19 EP disclosed
WO-1998004560-A1 SUBSTITUTED TRIAZOLO PYRIDAZINE DERIVATIVES AS INVERSE AGONISTS OF THE GABAAα5 RECEPTOR SUBTYPE MERCK SHARP & DOHME LIMITED (GB) 1998-02-05 WO disclosed
WO-1998004559-A2 SUBSTITUTED TRIAZOLO-PYRIDAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS MERCK SHARP & DOHME LIMITED (GB) 1998-02-05 WO disclosed
EP-0138748-B1 FLUOROALIPHATIC -THIO, -SULFINYL OR -SULFONYL SUBSTITUTED BICYCLOALIPHATIC AMIC ACID AMINE SALTS AND COMPOSITIONS AND USE THEREOF CIBA-GEIGY AG (CH) 1987-01-21 EP disclosed
US-4590129-A OIL AND WATER REPELLENT FOR CELLULOSE AND POLYAMIDES CIBA-GEIGY CORPORATION (US) 1986-05-20 US disclosed
US-4515640-A RENDERING CELLULOSE AND POLYAMIDES OIL AND WATER REPELLENT CIBA GEIGY CORPORATION (US) 1985-05-07 US disclosed
EP-0138748-A1 Fluoroaliphatic -thio, -sulfinyl or -sulfonyl substituted bicycloaliphatic amic acid amine salts and compositions and use thereof CIBA-GEIGY AG (CH) 1985-04-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250179054-A1 THRB RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD AND USE THEREOF THRB, THRA, TRHR TSHR 4/4885TDP1 3432/4885KDM4E 3160/4885
US-12534606-B2 Functionalized propylene based elastomer composition and method of making F8, CCT8, MSTN TSHR 769/4885TDP1 3597/4885KDM4E 2745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.